Hydroxyapatite-doped alginate beads as scaffolds for the osteoblastic differentiation of mesenchymal stem cells.

This work investigates the role of an osteoblastic matrix component, hydroxyapatite (HA), in modular alginate scaffolds to support osteoblastic differentiation of human mesenchymal stem cells for the purpose of tissue engineered bone constructs. This system is first evaluated in a tubular perfusion bioreactor, which has been shown to improve osteoblastic differentiation over static culture conditions. HMSCs in alginate scaffolds that contain HA show increased osteoblastic gene expression compared to cells in pure alginate scaffolds, as well as significantly more matrix production and mineralization. The differentiated hMSCs and cell-laid matrix are ultimately evaluated in an in vivo site specific model. Implantation of these scaffolds with preformed matrix into the rat femoral condyle defects results in abundant bone growth and significant incorporation of the scaffold into the surrounding tissue. The developed mineralized matrix, induced in part by the HA component in the scaffold, could lead to increased tissue development in critically sized defects, and should be included in future implant strategies. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 2325-2333, 2016.

[1]  E. Evans.  Toxicity of hydroxyapatite in vitro: the effect of particle size. , 1991, Biomaterials.

[2]  L. Rimondini,et al.  Characterization of bone defect repair in young and aged rat femur induced by xenogenic demineralized bone matrix. , 2002, Journal of periodontology.

[3]  J. Fisher,et al.  Soft and hard tissue response to photocrosslinked poly(propylene fumarate) scaffolds in a rabbit model. , 2002, Journal of biomedical materials research.

[4]  D. Mooney,et al.  Controlling rigidity and degradation of alginate hydrogels via molecular weight distribution. , 2004, Biomacromolecules.

[5]  M. Jäger,et al.  The critical size bony defect in a small animal for bone healing studies (II): Implant evolution and surgical technique on a rat's femur / Der kritische Knochendefekt am Kleintier zur Untersuchung der Knochenheilung (II): Implantatentwicklung und Operationstechnik am Rattenfemur , 2005, Biomedizinische Technik. Biomedical engineering.

[6]  Yi Zuo,et al.  Biocompatibility and osteogenesis of biomimetic nano-hydroxyapatite/polyamide composite scaffolds for bone tissue engineering. , 2007, Biomaterials.

[7]  David Dean,et al.  Effect of initial cell seeding density on early osteogenic signal expression of rat bone marrow stromal cells cultured on cross-linked poly(propylene fumarate) disks. , 2009, Biomacromolecules.

[8]  David Dean,et al.  Stereolithographic bone scaffold design parameters: osteogenic differentiation and signal expression. , 2010, Tissue engineering. Part B, Reviews.

[9]  John P Fisher,et al.  Macroporous hydrogels upregulate osteogenic signal expression and promote bone regeneration. , 2010, Biomacromolecules.

[10]  John P Fisher,et al.  Tubular perfusion system for the long-term dynamic culture of human mesenchymal stem cells. , 2011, Tissue engineering. Part C, Methods.

[11]  Jaebeom Lee,et al.  Nanoscale hydroxyapatite particles for bone tissue engineering. , 2011, Acta biomaterialia.

[12]  J. Fisher,et al.  Bone tissue engineering bioreactors: dynamic culture and the influence of shear stress. , 2011, Bone.

[13]  J. Fisher,et al.  Early osteogenic signal expression of rat bone marrow stromal cells is influenced by both hydroxyapatite nanoparticle content and initial cell seeding density in biodegradable nanocomposite scaffolds. , 2011, Acta biomaterialia.

[14]  J. Fisher,et al.  Tubular perfusion system culture of human mesenchymal stem cells on poly-L-lactic acid scaffolds produced using a supercritical carbon dioxide-assisted process. , 2012, Journal of biomedical materials research. Part A.

[15]  J. Fisher,et al.  Human mesenchymal stem cell position within scaffolds influences cell fate during dynamic culture , 2012, Biotechnology and bioengineering.

[16]  J. Jansen,et al.  Evaluation of bone regeneration using the rat critical size calvarial defect , 2012, Nature Protocols.

[17]  A. Mikos,et al.  Scaffold/Extracellular Matrix Hybrid Constructs for Bone‐Tissue Engineering , 2013, Advanced healthcare materials.

[18]  Mauro Alini,et al.  A Standardized Critical Size Defect Model in Normal and Osteoporotic Rats to Evaluate Bone Tissue Engineered Constructs , 2014, BioMed research international.

[19]  J. Fisher,et al.  In vivo bone regeneration using tubular perfusion system bioreactor cultured nanofibrous scaffolds. , 2014, Tissue engineering. Part A.

[20]  van den BeuckenJeroen J.J.P.,et al.  Osteoporotic rat models for evaluation of osseointegration of bone implants. , 2014 .

[21]  Bao-Ngoc B. Nguyen,et al.  Tubular perfusion system for chondrocyte culture and superficial zone protein expression. , 2015, Journal of biomedical materials research. Part A.

[22]  Bao-Ngoc B. Nguyen,et al.  Tunable osteogenic differentiation of hMPCs in tubular perfusion system bioreactor , 2016, Biotechnology and bioengineering.